Published in HIV Med on January 01, 2002
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med (2010) 2.94
Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther (2007) 2.65
Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J (2010) 1.57
The macrophage: the intersection between HIV infection and atherosclerosis. J Leukoc Biol (2009) 1.55
Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome. Biomark Med (2008) 1.55
Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation. AIDS (2011) 1.42
Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis. Curr Opin HIV AIDS (2010) 1.28
Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons. J Virol (2006) 1.24
CD8 T cells modulate CD4 T-cell and eosinophil-mediated pulmonary pathology in pneumocystis pneumonia in B-cell-deficient mice. Am J Pathol (2006) 1.08
MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts. BMC Infect Dis (2013) 1.00
Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy. Curr Opin HIV AIDS (2008) 1.00
Immune Restoration Inflammatory Syndromes: The Dark Side of Successful Antiretroviral Treatment. Curr Infect Dis Rep (2003) 0.96
Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy. Continuum (Minneap Minn) (2012) 0.95
HIV and co-infections. Immunol Rev (2013) 0.92
Exosomes from HIV-1-infected Cells Stimulate Production of Pro-inflammatory Cytokines through Trans-activating Response (TAR) RNA. J Biol Chem (2015) 0.90
Cryptococcus-Related Immune Reconstitution Inflammatory Syndrome(IRIS): Pathogenesis and Its Clinical Implications. Curr Fungal Infect Rep (2011) 0.90
Multi-analyte profiling of ten cytokines in South African HIV-infected patients with Immune Reconstitution Inflammatory Syndrome (IRIS). AIDS Res Ther (2010) 0.90
LPS-binding protein and IL-6 mark paradoxical tuberculosis immune reconstitution inflammatory syndrome in HIV patients. PLoS One (2013) 0.89
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. World J Virol (2013) 0.88
Role of IL-6 in Mycobacterium avium--associated immune reconstitution inflammatory syndrome. J Immunol (2013) 0.85
TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB. AIDS (2015) 0.83
T Cell Activation and Cytokine Profile of Tuberculosis and HIV-Positive Individuals during Antituberculous Treatment and Efavirenz-Based Regimens. PLoS One (2013) 0.78
Immunological Signaling During Herpes Simplex Virus-2 and Cytomegalovirus Vaginal Shedding After Initiation of Antiretroviral Treatment. Open Forum Infect Dis (2016) 0.78
The effect of alcohol use on IL-6 responses across different racial/ethnic groups. Future Virol (2012) 0.78
The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrum. Curr Opin Infect Dis (2016) 0.78
Leishmaniasis-HIV coinfection: current challenges. HIV AIDS (Auckl) (2016) 0.76
[Immune reconstitution inflammatory syndrome (IRIS) of the small bowel in an immunocompromised patient suffering from systemic lupus erythematosus and non-tuberculous mycobacteriosis]. Z Rheumatol (2008) 0.76
Leishmaniasis as a Manifestation of Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV-Infected Patients: A Literature Review. J Int Assoc Provid AIDS Care (2014) 0.75
Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune Activation. Front Immunol (2016) 0.75
Neuro-oncology family caregivers are at risk for systemic inflammation. J Neurooncol (2016) 0.75
Immune response to Leishmania antigens in an AIDS patient with mucocutaneous leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome (IRIS): a case report. BMC Infect Dis (2015) 0.75
Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol (1986) 3.07
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer (2005) 2.85
How should we introduce clinical PET in the UK? The oncologists need to have a view. Clin Oncol (R Coll Radiol) (2004) 2.56
Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med (1988) 2.52
Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc Natl Acad Sci U S A (1987) 2.46
Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med (2000) 2.37
Simplified chromatographic separation of immunoglobulin M from G and its application to toxoplasma indirect immunofluorescence. J Clin Microbiol (1979) 2.22
Expression of cloned hepatitis B virus DNA in human cell cultures. Proc Natl Acad Sci U S A (1980) 2.08
Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera. Clin Exp Immunol (1984) 1.99
Non-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology. Clin Oncol (R Coll Radiol) (1995) 1.82
Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J Virol (1993) 1.77
HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J Virol (1993) 1.58
Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. N Engl J Med (1991) 1.58
Correlation between hypomethylation of DNA and expression of globin genes in Friend erythroleukemia cells. Eur J Biochem (1977) 1.57
Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology? Eur J Nucl Med (1997) 1.55
The cost-effectiveness of wound management protocols of care. Br J Nurs (2000) 1.52
An assessment of clinically optimal gold marker length and diameter for pelvic radiotherapy verification using an amorphous silicon flat panel electronic portal imaging device. Br J Radiol (2005) 1.50
Systemic antibody deficiency in patients without serum immunoglobulin deficiency or with selective IgA deficiency. Clin Exp Immunol (1984) 1.48
Coping style and depression influence the healing of diabetic foot ulcers: observational and mechanistic evidence. Diabetologia (2010) 1.47
Staphylococcal IgE antibodies, hyperimmunoglobulinemia E and Staphylococcus aureus infections. N Engl J Med (1979) 1.47
Influence of dietary protein restriction on immune competence. II. Effect on lymphoid tissue. Clin Exp Immunol (1976) 1.40
Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006. HIV Med (2007) 1.40
Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol (1993) 1.39
Chain shortening of palmitic acid in human subjects. Am J Clin Nutr (1988) 1.39
Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J Exp Med (1993) 1.38
Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? AIDS (1998) 1.38
Recognizing the feet as being at risk from pressure damage. Br J Nurs (2002) 1.38
Cerebral mass lesions due to cytomegalovirus in patients with AIDS: report of two cases. J Infect (1995) 1.38
Evaluation of quality of contents of general practice records. Br Med J (Clin Res Ed) (1984) 1.38
Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol (1984) 1.37
Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology (2009) 1.35
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. Br J Radiol (2003) 1.27
Parametric image reconstruction using spectral analysis of PET projection data. Phys Med Biol (1998) 1.26
Identification of protein-binding sites in the hepatitis B virus enhancer and core promoter domains. Mol Cell Biol (1988) 1.26
The role of D-1 and D-2 receptors. Nature (1980) 1.24
The toxicity of inactivated bacteria and endotoxin in mice suffering from protein malnutrition. J Reticuloendothel Soc (1975) 1.23
Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case report. AIDS (1997) 1.22
Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med (2003) 1.21
64Cu metabolism in Menkes and normal cultured skin fibroblasts. Pediatr Res (1978) 1.21
Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer. Int J Cancer (1988) 1.19
Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review. Eur J Clin Microbiol Infect Dis (2008) 1.16
Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk? QJM (2003) 1.16
Drug quantitation on a benchtop liquid chromatography-tandem mass spectrometry system. J Chromatogr A (1997) 1.15
The direct calculation of parametric images from dynamic PET data using maximum-likelihood iterative reconstruction. Phys Med Biol (1997) 1.14
Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med (2008) 1.12
Inhibition of dimethyl sulfoxide-stimulated Friend cell erythrodifferentiation by hydrocortisone and other steroids. Proc Natl Acad Sci U S A (1978) 1.11
Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol (2001) 1.11
Exposure to blood borne infections in health care workers. Med J Aust (1992) 1.10
Effect of topical acidulated phosphate fluoride on percentage of Streptococcus mutans and Streptococcus sanguis in plaque. II. Pooled occulusal and pooled approximal samples. Caries Res (1975) 1.10
Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis. J Immunol (2001) 1.10
Outcomes in controlled and comparative studies on non-healing wounds: recommendations to improve the quality of evidence in wound management. J Wound Care (2010) 1.09
Common HLA-B8-DR3 haplotype in Northern India is different from that found in Europe. Tissue Antigens (2002) 1.09
Species composition and seasonal abundance of stink bugs (Hemiptera: Pentatomidae) in Louisiana soybean. Environ Entomol (2013) 1.09
The response of protein-deficient mice to tetanus toxoid. Effects of antigen dose, adjuvants, period of deprivation and age on antibody production. Immunology (1977) 1.08
Recommended distributions for exposure factors frequently used in health risk assessment. Risk Anal (1994) 1.08
A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol (1992) 1.08
The IgG4 subclass is associated with a low affinity antibody response to tetanus toxoid in man. Immunology (1985) 1.05
Characterization of RNA transcripts and virally coded proteins synthesized in mouse fibroblasts transfected with hepatitis B DNA: HBeAg synthesis in HBcAg-negative cells with active core-antigen genes. Biosci Rep (1983) 1.05
Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy. J Infect Dis (2001) 1.05
Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant (2000) 1.05
Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis (2012) 1.02
Factors determining the effects of chronic protein-deficiency on antibody responses to sheep red blood cells and Brucella abortus vaccine in mice. Aust J Exp Biol Med Sci (1977) 1.02
Protein losing enteropathy due to systemic lupus erythematosus. Gut (1984) 1.02
The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia. HIV Med (2008) 1.01
Walking performance in people with diabetic neuropathy: benefits and threats. Diabetologia (2006) 1.01
ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab (1996) 1.01
High-intensity focused ultrasound: advances in technology and experimental trials support enhanced utility of focused ultrasound surgery in oncology. Br J Radiol (2013) 1.00
Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster. Hum Immunol (1999) 1.00
DNA cloned from the ayw subtype of hepatitis B virus. J Med Virol (1980) 1.00
Murine cytomegalovirus binds reversibly to mouse embryo fibroblasts: implications for quantitation and explanation of centrifugal enhancement. J Virol Methods (1988) 0.99
N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol (1997) 0.99
Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum Immunol (1990) 0.99
Novel sensitive real-time PCR for quantification of bacterial 16S rRNA genes in plasma of HIV-infected patients as a marker for microbial translocation. J Clin Microbiol (2011) 0.98
T cell recognition of Epstein-Barr virus associated lymphomas. Cancer Surv (1992) 0.98
Measurement of functional recovery in individuals with acute anterior cruciate ligament rupture. Br J Sports Med (2005) 0.98
Single scan parameterization of space-variant point spread functions in image space via a printed array: the impact for two PET/CT scanners. Phys Med Biol (2011) 0.97
Benzene toxicity and risk assessment, 1972-1992: implications for future regulation. Environ Health Perspect (1993) 0.97
Evaluation of Ki-67 monoclonal antibody as prognostic indicator for prostatic carcinoma. Br J Urol (1993) 0.97
Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic lupus erythematosus. J Clin Lab Immunol (1985) 0.96
The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection. Immunology (1997) 0.96
Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000. J Clin Oncol (2003) 0.96
Captopril: reversible renal failure with severe hyperkalaemia. Lancet (1980) 0.96
Clinical and laboratory features of invasive community-onset methicillin-resistant Staphylococcus aureus infection: a prospective case-control study. Eur J Clin Microbiol Infect Dis (2010) 0.95
Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays. J Clin Lab Immunol (1983) 0.95
Epidemiology of late presentation of HIV infection in Western Australia. Med J Aust (1992) 0.95
Developments in and experience of kilovoltage X-ray cone beam image-guided radiotherapy. Br J Radiol (2006) 0.94
Gastrointestinal cytomegalovirus infection in a homosexual man with severe acquired immunodeficiency syndrome. Gastroenterology (1983) 0.94
Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease. J Antimicrob Chemother (2006) 0.93
An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy. Clin Exp Immunol (2001) 0.93
The effect of topical acidulated fluoride on percentage of Streptococcus mutans and Streptococcus sanguis in interproximal plaque samples. Caries Res (1973) 0.93
Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity. J Immunol Methods (2012) 0.92
The central MHC gene, BAT1, may encode a protein that down-regulates cytokine production. Genes Cells (2001) 0.92
Irregular reporting of tuberculosis cases by laboratories in Nassau County, N.Y. Public Health Rep (1974) 0.92
Engineering mammalian cells for solid-state sensor applications. Biosens Bioelectron (2001) 0.92
Transrectal high-intensity focused ultrasonography is feasible as a new therapeutic option for advanced recurrent rectal cancer: report on the first case worldwide. Ann R Coll Surg Engl (2011) 0.92